Skip to content

DOKTER ERWIN SCHROYENS

Active
Private limited companyfounded 2002active for 24 yearsStuivenbergvaart 102, 2800 Mechelen, BelgiumKBO/BCE: BE 0476.755.988
Summary

DOKTER ERWIN SCHROYENS has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €612,575 and a net result of €55,349. Equity has been shrinking by about 3.2% per year since 2019. Its solvency ranks better than 94% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 24-01-2002 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.196.040.606 2800 Mechelen, since 18-01-2002
Financial year end
30 September
Peppol
Reachable since 16-09-2025

Board and ownership

Board
  • Schroyens ErwinDirector · since 18-01-2002

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-09-2025
Gross margin
€91,211
▼ 84.7%
Turnover
≈ €210,000
estimated
Profit
€55,349
▼ 86.1%
Equity
€612,575
▲ 7.6%
Total assets
€633,692
▲ 1.9%
Filed on 28-04-2026, 2 days before the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 29.81, cash €114,579Equity €612,575 (96.7% of total assets)Size: total assets €633,692Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 53% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 96.7% of total assets
Liquidity 73+2
short-term debt 3.3% · cash 18.1%
Profitability 80-20
return on assets 8.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025highest value 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €55,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 29.81 (11.41 in 2024), above the usual 1.5. Short-term debt is 3.3% and cash 18.1% of total assets. 3.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 54% on liquidity, 26% on profitability and 49% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 29.81, cash €114,579
NBB · annual accounts
lowers risk · Equity €612,575 (96.7% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €633,692
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
19202122232425
2019 to 2025 · latest year €612,575
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 28-04-2026, 2 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
2 days early
2024
2 days early
2023
18 days early
2022
2 days early
2021
2 days early
2020
28 days early
2019
9 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 9 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 28 April (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end01-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 94% of companies in human healthsector median 63.0% · 20,678 companies 96.7% View
  • Result fell in 2025the 2024 profit included a one-off income of €524,707 ▼ 86.1% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View

Recent changes

  1. · Gazette deed Incorporation
All 18 events

Comparable companies

These companies have the same main activity as DOKTER ERWIN SCHROYENS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €560,000 and €700,000, founded between 1998 and 2002.

CompanyTotal assetsGross margin
DOKTER ERWIN SCHROYENS Mechelen€633,692€91,211
DR. PH. ALBERTYN Aartselaar€560,490€85,919
DR. JANKIE SASKIA Malle€699,699€100,338
DOKTER RITA VAN GINDERDEUREN Diest€647,724€93,678
CABINET MEDICAL DU DOCTEUR WALRAVENS Thuin€618,577€98,739
ORTHODES Péruwelz€618,350€94,535
Clinique du Mont Saint Martin Liège€671,826€80,552
Full comparison

Key facts about DOKTER ERWIN SCHROYENS

What is the company number of DOKTER ERWIN SCHROYENS?
The company number of DOKTER ERWIN SCHROYENS is 0476.755.988. The VAT number is the same number with BE in front: BE 0476.755.988.
Where is DOKTER ERWIN SCHROYENS based?
The registered office is at Stuivenbergvaart 102, 2800 Mechelen.Company details
What does DOKTER ERWIN SCHROYENS do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DOKTER ERWIN SCHROYENS?
The legal form of DOKTER ERWIN SCHROYENS is Private limited company (BV).
When was DOKTER ERWIN SCHROYENS founded?
DOKTER ERWIN SCHROYENS was founded on 24-01-2002.
Is DOKTER ERWIN SCHROYENS still active?
Yes, DOKTER ERWIN SCHROYENS is an active enterprise in the KBO register.
What is the turnover of DOKTER ERWIN SCHROYENS?
The turnover in financial year 2025 is ≈ €210,000. This figure is estimated from the gross margin of €91,211 and 32 comparable companies (NACE 862). It probably lies between €160,000 and €260,000.Financials
Is DOKTER ERWIN SCHROYENS profitable?
In financial year 2025, DOKTER ERWIN SCHROYENS made a profit of €55,349.
Where can I find the annual accounts of DOKTER ERWIN SCHROYENS?
DOKTER ERWIN SCHROYENS filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTER ERWIN SCHROYENS due?
DOKTER ERWIN SCHROYENS must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.